2seventy bio
TSVT
TSVT was delisted on the 13th of May, 2025.
116 hedge funds and large institutions have $183M invested in 2seventy bio in 2024 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 30 reducing their positions, and 19 closing their positions.
2,436% more call options, than puts
Call options by funds: $1.06M | Put options by funds: $42K
23% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 30
1.44% more ownership
Funds ownership: 91.18% → 92.62% (+1.4%)
6% more capital inflows, than outflows
Capital inflows: $27.1M | Capital outflows: $25.6M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 19
1% less funds holding
Funds holding: 117 → 116 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NM
Newtyn Management
New York
|
+$11.2M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$7.95M |
| 3 |
F1I
Fund 1 Investments
Rincon,
Puerto Rico
|
+$1.75M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.01M |
| 5 |
VM
Venator Management
Pittsburgh,
Pennsylvania
|
+$721K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.63M |
| 2 |
Morgan Stanley
New York
|
-$4.9M |
| 3 |
JP Morgan Chase
New York
|
-$1.94M |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$1.35M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$1.21M |
TSVT Hedge Fund Activity: Q2 2024 in Review
116 of the 6,946 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q2 2024, worth a combined $183M — down 27% from $251M a quarter earlier.
Fund positioning in TSVT was balanced in Q2 2024: 19 funds opened new positions, 19 closed out, 37 added to existing stakes and 30 trimmed.
The largest buyer was Newtyn Management, opening a new position worth an estimated $11.2M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $8.63M sold.
- 116 institutional investors held 2seventy bio (TSVT) as of Q2 2024, down from 117 in Q1 2024.
- Funds reported $183M of 2seventy bio stock for Q2 2024, down 27% quarter-over-quarter.
- 19 funds opened new 2seventy bio positions in Q2 2024 and 19 closed out, a net change of 0 holders.
- The largest 2seventy bio buyer in Q2 2024 was Newtyn Management, an estimated $11.2M added.
- The largest 2seventy bio seller in Q2 2024 was Point72 Asset Management, an estimated $8.63M sold.
Based on aggregated 13F filings for Q2 2024.